These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25130511)

  • 21. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus.
    Liu JB; Zhang Z
    J Virol Methods; 2008 Apr; 149(1):129-35. PubMed ID: 18280587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC; van der Beek MT; van der Blij-de Brouwer CS; van der Heiden PL; Marijt EW; Spaan WJ; Claas EC; Nederstigt C; Vossen AC; Snijder EJ; Kroes AC
    J Clin Virol; 2011 May; 51(1):25-30. PubMed ID: 21388868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients.
    Benzi F; Vanni I; Cassina G; Ugolotti E; Di Marco E; Cirillo C; Cristina E; Morreale G; Melioli G; Malnati M; Biassoni R
    J Clin Virol; 2012 May; 54(1):48-55. PubMed ID: 22300656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.
    Baldanti F; Lilleri D; Campanini G; Comolli G; Ridolfo AL; Rusconi S; Gerna G
    J Antimicrob Chemother; 2004 Mar; 53(3):536-9. PubMed ID: 14739146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
    Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
    J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
    J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
    Baldanti F; Gerna G
    J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
    Germi R; Mariette C; Alain S; Lupo J; Thiebaut A; Brion JP; Epaulard O; Saint Raymond C; Malvezzi P; Morand P
    Antiviral Res; 2014 Jan; 101():57-61. PubMed ID: 24184983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug susceptibility and UL97 gene mutation analysis of cytomegalovirus in recipients of hematopoietic stem cell transplantation].
    Zeng A; Dong D; Cui X; Guo M; Zou D; Fang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):519-22. PubMed ID: 24752100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to drug-resistant cytomegalovirus in transplant recipients.
    Chou S
    Curr Opin Infect Dis; 2015 Aug; 28(4):293-9. PubMed ID: 26098499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
    Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
    Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients.
    Gilbert C; Roy J; Belanger R; Delage R; Beliveau C; Demers C; Boivin G
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3669-71. PubMed ID: 11709367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
    Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
    Isegawa Y; Hara J; Amo K; Osugi Y; Takemoto M; Yamanishi K; Fukunaga R; Shibata M; Ohshima A; Horiguchi Y; Sugimoto N
    J Clin Virol; 2009 Jan; 44(1):15-9. PubMed ID: 18952495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
    Garrigue I; Moulinas R; Recordon-Pinson P; Delacour ML; Essig M; Kaminski H; Rerolle JP; Merville P; Fleury H; Alain S
    J Clin Virol; 2016 Jul; 80():74-81. PubMed ID: 27214758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model.
    Hantz S; Cotin S; Borst E; Couvreux A; Salmier A; Garrigue I; Merville P; Mengelle C; Attal M; Messerle M; Alain S
    Antiviral Res; 2013 Apr; 98(1):130-4. PubMed ID: 23415883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.